Search Press releases Keywords From To 4 Feb 2022 Disposals of own shares Read More 4 Feb 2022 UCB announces positive data in myasthenia gravis with zilucoplan phase 3 study results Read More 2 Feb 2022 Transparency notification FMR LLC. Read More 2 Feb 2022 UCB Receives Positive CHMP Opinion Recommending Approval of BRIVIACT[®] (brivaracetam) and VIMPAT[®] (lacosamide) in the EU for Partial-Onset Seizures in Pediatric Patients From Two to Four Years Read More 1 Feb 2022 UCB Commences Tender Offer to Acquire Zogenix, Inc. Read More 28 Jan 2022 Disposals of own shares Read More Pagination First page Previous page Previous … Page 46 Page 47 Page 48 Page 49 Current page 50 Page 51 Page 52 Page 53 Page 54 … Page 50 of 65 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
